Artelo Biosciences, Inc. (ARTL) vs Cellyan Biotechnology Co., Ltd (HKPD)
A side-by-side comparison of Artelo Biosciences, Inc. and Cellyan Biotechnology Co., Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTL
Artelo Biosciences, Inc.
$3.56HealthcareDelayed quote: Oct 6, 2026, 1:47 PM EDT
HKPD
Cellyan Biotechnology Co., Ltd
$0.10HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
Total return — ARTL vs HKPD
growth of $100 · dividends reinvested · last 2yARTL -94.4% (-76.3%/yr)HKPD -96.3% (-80.8%/yr)ARTL compounded faster over this window
ARTL HKPD
ARTL vs HKPD: by the numbers
- •ARTL is the larger company ($1M vs $1M market cap).
- •Both run net losses; ARTL's is the smaller (0.00% vs -8.46% net margin).
Metrics side by side
Valuation
| Metric | ARTL | HKPD |
|---|---|---|
| P/B ratio | 0.28 | 0.12 |
Profitability
| Metric | ARTL | HKPD |
|---|---|---|
| Gross margin | 0.00% | 10.32% |
| Operating margin | 0.00% | -7.41% |
| Net margin | 0.00% | -8.46% |
| ROE | -253.57% | -11.85% |
| ROIC | -219.36% | -9.45% |
Growth (annualized)
| Metric | ARTL | HKPD |
|---|---|---|
| Total return CAGR (5Y) | -64.27% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.